Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down Syndrome

ConditionDown Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-14
SponsorRiphah International University

About this trial

The study will use a quasi-experimental design conducted over ten months in pediatric physiotherapy departments of tertiary care hospitals and special education schools. It will include 30 children aged 6-14 years with mild to moderate intellectual disability, selected after eligibility screening and guardian consent. Outcomes will be assessed using BOT-2, Berg Balance Scale, MMSE-C, and Six-Minute Walk Test to measure motor skills, balance, cognition, and endurance. Ethical approval will be obtained from the Research Ethical Committee of Riphah International University, Lahore, and data will be analyzed using SPSS version 26.0.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Clinically diagnosed with Trisomy 21.

Aged between 8-14 years.(29)

Able to follow basic verbal instructions.

Ambulatory with or without assistive devices

Disqualifiers

• Severe visual or auditory impairments.

Patient with moderate to severe cognitive impairments. (29)

Co-morbid neurological conditions (e.g., uncontrolled seizures, cerebral palsy).

Cardiac contraindications to moderate physical activity

Trial design

Design model

Single group

Treatments tested in this trial

  • OTAGO Exercises

    Other intervention

    1. WarmUp (510 mins) Marching on the spot Gentle arm swings Neck, shoulder, ankle movements 2. Strength Exercises (3 times/week using ankle weights): Knee Extensions (seated leg straightening) Knee Flexions (standing leg curls) Hip Abductions (leg lifts to the side) Hip Extensions (leg lifts backward) Calf Raises (rise onto toes, holding support) Toe Raises (lift toes while heels remain on ground) 3. Balance Exercises (at least 3 times/week): Heel to Toe Stand One Leg Stand Sit to Stand (from a chair, arms crossed) Turning Around (slow 360 degree turns) Backwards Walking Walking and Turning Head Sideways Walking Stair Climbing 4. Walking Plan: At least 30 minutes of walking, twice weekly 5. Progression: Gradually increase intensity, duration, repetitions 6. Duration: Typical duration 8 weeks

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: OTAGO ExercisesExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Bruininks-Oseretsky Test of Motor Proficiency

The BOT-2 balance subtest evaluates motor control required for maintaining posture during standing, walking, and functional activities. It assesses balance through tasks measuring body stability, movement and stopping ability, and reliance on visual cues, including standing and walking under different conditions. Participants perform multiple tasks with two attempts allowed, and the best performance is recorded for scoring.

Time frame
Baseline, 8 weeks
2

Berg Balance Scale

The Berg balance scale is a clinical assessment of functional balance. It consists of 14 functional tasks of increasing difficulty, and each is scored on a scale ranging from 0 to 4 (task is performed independently = 4; unable to complete the task = 0). The maximum possible score is 56 which indicates no identifiable balance difficulties

Time frame
Baseline, 8 weeks
3

Mini Mental State Examination (MMSE)

This tool is used for cognitive assessment. The MMSE remains one of the most widely applied instruments for screening cognitive impairment, particularly in dementia, Alzheimer's disease, stroke, and general geriatric assessments.

Time frame
Baseline, 8 weeks
4

Six-Minute-Walk-Test (6MWT)

The Six-Minute Walk Test (6MWT) is a simple, low-cost, and reliable tool used to assess functional exercise capacity and endurance, especially in individuals with moderate impairments. It measures the distance a participant can walk in six minutes under standardized conditions while monitoring vital signs and symptoms.

Time frame
Baseline, 8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.